Background-Genome-wide single marker and gene-based meta-analyses of long-term average (LTA) blood pressure (BP) phenotypes may reveal novel findings for BP. ). Three previously reported BP loci (WBP1L, NT5C2, and ATP2B1) were also identified for all BP phenotypes. Gene-based analysis provided the first robust evidence for association of KCNJ11 with LTA systolic BP (stage-1 P=8.55×10 ) phenotypes. Fourteen genes (TMEM180, ACTR1A, SUFU, ARL3, SFXN2, WBP1L, CYP17A1, C10orf32, C10orf32-ASMT, AS3MT, CNNM2, and NT5C2 at 10q24.32; ATP2B1 at 12q21.33; and NCR3LG1 at 11p15.1) implicated by previous genome-wide association study meta-analyses were also identified. Among the loci identified by the previous genome-wide association study meta-analysis of LTA BP, we transethnically replicated associations of the KCNK3 marker rs1275988 at 2p23.3 with LTA systolic BP and mean arterial pressure phenotypes (P=1.27×10 −4 and 3.30×10 −4
1-
4 BP has been long established as an inheritable trait, with heritability estimates ranging from 30% to 60% in pedigree data to as high as 70% in twin studies. 5, 6 Although genome-wide association studies (GWASs) have identified many genetic loci underlying BP regulation, they together explain only a small proportion of the heritability of this complex trait. 7 A recent GWAS meta-analysis suggested that averaging BP measured across time could improve phenotypic accuracy and thereby increase statistical power to detect genetic associations. 8 Long-term average (LTA) BP, which has been shown to predict future cardiovascular disease events beyond a singlevisit measurement of BP, 9 may more accurately reflect cumulative burden of elevated BP. 10 Although GWAS meta-analyses
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of LTA BP is potentially useful for identifying novel genes or genetic variants underlying BP regulation, such studies have yet to be conducted in an Asian population.
In the current study, we aimed to identify novel genetic variants and genes influencing BP regulation by conducting GWAS meta-analyses of LTA systolic BP (SBP), LTA diastolic BP (DBP), LTA mean arterial pressure (MAP), and LTA pulse pressure (PP) among 18 422 participants of the Asian Genetic Epidemiology Network (AGEN) consortium. Furthermore, we attempted transethnic replication of novel LTA BP loci previously identified by the predominantly European Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Methods

Stage-1 GWAS Meta-Analysis
Study Population
The AGEN consortium was established to facilitate the identification of genetic variants influencing cardiovascular disease-related traits among populations of Asian ancestry. For the current study, we included AGEN GWAS with at least 2 BP measures collected at least 1 year apart, including DFTJ-Cohort study (Dongfeng-Tongji cohort), the GenSalt (Genetic Epidemiology Network of Salt-Sensitivity), KARE (Korean Association Resource Project), Chinese participants of MESA (Multi-Ethnic Study of Atherosclerosis), NHAPC (Nutrition and Health of Aging Population in China), SiMES (Singapore Malay Eye Survey), SP2 (Singapore Prospective Study Program), TWT2DS (Taiwan Type 2 Diabetes Study), and the TUDR study (Taiwan-US Diabetic Retinopathy). All study participants provided written informed consent, and approval was obtained from the institutional review board from the respective local institutions. Detailed descriptions of these 9 studies are presented in the Data Supplement.
Genotype Data and Quality Control
All studies imputed ≈2.4 million single-nucleotide polymorphisms (SNP) from the HapMap release 22 build 36 CHB+JPT samples. SNPs with minor allele frequency <0.05, Hardy-Weinberg P value <1×10 −6 , call rate <95%, or imputation quality score r 2 <0.5 were excluded before performing genome-wide analysis. Detailed information on genotyping, imputation, quality control measures before and after imputation, and genomic control before meta-analysis according to AGEN studies are shown in Table I Data Supplement.
Phenotype Harmonization
Each AGEN study collected at least 2 measurements of SBP and DBP collected at least 1 year apart in a clinical setting using standard methods as described previously. 11 At each study visit, for those taking antihypertensive medication, BP was imputed by adding 10 and 5 mm Hg to SBP and DBP, respectively. Mean MAP and PP were calculated for each participant from SBP and DBP values as MAP=SBP/3+2×DBP/3 and PP as PP=SBP−DBP. For each follow-up visit, the 4 BP phenotypes were first Winsorized at 4 SDs in both tails. 8, 12 Specifically, if a BP value was >4 SDs above or below the mean, it was set exactly at 4 SDs from the mean. This was done in both tails and separately for each of the 4 BP variables. BP residuals were then calculated for each study visit by performing linear regression controlling for age, age 2 , sex, body mass index, enrollment site, and study-specific covariables (the first 2 principal components in MESA, SiMES, and TUDR). LTA BP was calculated by taking the average of the BP residuals over the available follow-up visits for study participants.
Single SNP Analysis
Imputed genotype data were analyzed using an additive genetic model. GWAS of adjusted LTA SBP, LTA DBP, LTA MAP, and LTA PP were conducted using linear regression models. Inverse-variance-weighted fixed-effect meta-analyses of LTA BP results from the 9 GWAS were performed using METAL software. 13 SNPs were further excluded if they had sample size <10 000 or showed evidence of heterogeneity across studies (P for Cochrane's Q test <1×10 −6 ). Genomic control was applied in each study before meta-analyses and in the final metaanalyses (λ=1.007 for LTA SBP and LTA DBP, 1.006 for LTA MAP, and 1.002 for LTA PP, respectively, in the final meta-analyses).
Gene-Based Analysis
SNPs within the 5 kbp flanking regions of a gene were assigned to the gene. SNPs in the overlapping region of ≥2 genes were assigned to each of the genes. SNP-based analysis results were used to generate gene-based P values using the Gene-based Analysis Using Extended Simes (GATES) procedure implemented in KGG software. 14 The GATES method uses an extended Simes test and integrates functional information and association evidence to combine the P values from single marker analyses within a gene to generate an overall P value for the association of the entire gene. This method has been shown to be more powerful than single SNP-based tests. Furthermore, the type I error rate is well controlled and independent of gene size and linkagedisequilibrium pattern among markers. 14 The GATES method has been adopted by many genome-wide gene-based studies. [15] [16] [17] [18] To explore whether the identified gene-based signal was driven by the most significant SNP in the gene, we performed sensitivity analysis excluding the most significant SNP in the identified gene using GATES method.
Stage-2 Replication Study and Joint Analysis
Single SNP Analysis
SNPs with a stage-1 P<1×10 −6 for LTA SBP, LTA DBP, LTA MAP, or LTA PP were carried forward for stage-2 replication analyses among participants of European ancestry in the CHARGE consortium. The CHARGE consortium is the only previous GWAS meta-analysis with results on LTA BP traits. 8 CHARGE consists of 46 629 participants of European ancestry from 8 longitudinal population studies, including the ARIC study (Atherosclerosis Risk in Communities), the CARDIA study (Coronary Artery Risk Development in Young Adults), the CHS (Cardiovascular Health Study), the FHS (Framingham Heart Study), the AGES Reykjavik study (Age, Gene/Environment Susceptibility), MESA, the RS (Rotterdam Study), and the WGHS (Women's Genome Health Study). Detailed descriptions of these studies are presented in the Data Supplement. The GWAS meta-analysis of LTA BP from the CHARGE consortium used an analysis protocol identical to that of the current study. Briefly, in CHARGE, BP phenotypes were harmonized using the same procedures as described in the current stage-1 analysis. Additive associations between SNPs and adjusted LTA BP phenotypes were evaluated separately in each study. Inverse-variance-weighted meta-analysis was used to combine results across studies. Genomic control was applied to individual study results and to the final meta-analysis results to control population stratification or cryptic relatedness.
After ensuring the strand orientation and coded alleles were the same, meta-analysis was again used to combine results across stage-1 and stage-2 findings. SNPs that achieved nominal significance (P<0.05) in stage-2 analysis and genome-wide significance (P<5.0×10 −8 ) in the joint analysis, with consistent effect directions across stages, were considered significant. For LTA BP loci previously reported in a European population, a Bonferroni P<0.05/3=1.67×10 −2 and consistency in effect direction was considered evidence of transethnic replication in the East Asian AGEN consortium.
Gene-Based Analysis
Genes with gene-based P<1×10 −4 were further evaluated for replication in the CHARGE consortium. Specifically, SNPs from promising genes in stage 1 were tested for associations with the corresponding LTA BP traits in the CHARGE consortium. SNP-based analysis results in CHARGE were used to generate gene-based P values using GATES. 14 The Fisher method was used to combine gene-based results across stage-1 and stage-2 findings. Genes with replication stage P<0.05 and combined P<2.5×10 −6 (Bonferroni corrected genome-wide significance level for gene-based analysis of 20 000 genes) were considered significant.
Variance Explained by Significant SNPs
We calculated variance explained (VarExp) by each significant SNP using the formula: VarExp=2EAF*(1−EAF)*β 2 , where β refers to the discovery stage meta-analysis association effect size and EAF refers to coded allele frequency. 19 We obtained the variance of SBP (18.32 mm Hg)2 and variance of DBP (10.31 mm Hg)2 by taking the weighted average of SDs of SBP and DBP, 7 respectively, across all 9 studies.
Results
The discovery stage analyses of LTA BP phenotypes were conducted among 18 422 East Asian participants. Characteristics, including age, body mass index, SBP, DBP at baseline and follow-up times are shown in Table 1 . In the discovery stage GWAS meta-analysis (stage 1), genome-wide significance (P<5.0×10 −8 ) was achieved for 7 SNP-BP associations at 4 loci. Borderline significance (5.0×10 −8 <P<1.0×10 Table 2 . The total variances explained by SBP and DBP loci were 0.37% and 0.25%, respectively. Although all of the identified loci have been reported previously, one novel variant was identified (r 2 <0.3 with previously reported SNPs). The novel ARL3 rs4919669 variant was associated with both LTA SBP (stage-1 P=5.03×10 −8 , stage-2 P=8.64×10 −3 , joint P=2.63×10 −8 ) and LTA MAP (stage-1 P=3.59×10 −9 , stage-2 P=2.35×10 −2 , joint P=2.64×10 −8 ). The remaining 9 SNP-BP associations were for independent variants at 3 previously identified loci including WBP1L, NT5C2, and ATP2B1.
Genome-wide gene-based analysis discovery stage results are shown in Figures V through VIII in the Data Supplement. A total of 18 genes reached suggestive significance (P<1.0×10 −4 ) for at least 1 LTA BP phenotype in the discovery stage and were evaluated for replication in stage-2 gene-based analysis. Fifteen genes were nominally significant (P<0.05) in the stage-2 gene-based analysis and reached genome-wide significance (P<2.5×10 −6 ) in the joint analysis of stage-1 and stage-2 studies. Gene-based analysis results of these 15 genes are shown in Table 3 . Novel gene KCNJ11 at 11p15.1 was replicated in stage-2 gene-based analysis and reached genome-wide genebased significance in the joint meta-analysis for LTA SBP and LTA MAP phenotypes. Sensitivity analysis excluding the most significant SNP, rs1002227 (P=3.26×10 −7 for PP and 3.03×10 −6 for SBP) in KCNJ11 showed that the gene was still significantly associated with SBP (P=2.55×10 −5 ) and PP (4.92×10 −6 ). The remaining 14 genes have been implicated by previous BP GWAS meta-analyses of single markers and include genes TMEM180, ACTR1A, SUFU, ARL3, SFXN2, WBP1L, CYP17A1, C10orf32, C10orf32-ASMT, AS3MT, CNNM2, and NT5C2 at 10q24.32 and ATP2B1 at 12q21.33 (which associated with LTA SBP, LTA DBP and LTA MAP phenotypes in the current study); and NCR3LG1 at 11p15.1 (which associated with LTA SBP and LTA MAP in the current study).
In addition, as presented in Table 4 , we transethnically replicated 2 associations at the 2p23.3 KCNK3 locus (rs1275988; P=1.27×10 −4 and 3.30×10 −4 for LTA SBP and LTA MAP, respectively), which had been previously identified among European participants of the CHARGE consortium and verified for only single-visit BP associations in East Asians. 8 The other 2 variants rs7599598 at 2q11 and rs10948071 at 6p21 reached nominal significance (P=0.0236 and 0.0361, respectively) in our study but were not significant after adjustment for multiple testing. We identified a novel ARL3 gene variant, rs4919669 at 10q24.32, associated with LTA SBP and LTA MAP in the current study. Although the variant appears novel, this locus has been identified previously. Three highly correlated variants including rs1004467, rs11191548, and rs3824755 (r 2 >0.7) were reported in previous GWAS meta-analyses of BP, including the BP GWAS meta-analysis conducted in East Asian participants. 7, 11, [20] [21] [22] [23] The 3 SNPs were all associated with BP phenotypes in the current discovery stage analysis with P values ranging from 1.53×10 −6 to 4.81×10 −9 . The variant rs4919669 identified in our study is not in linkage disequilibrium with any of these 3 SNPs in East Asians, indicating that this signal may reflect a different causal variant from that captured by rs1004467, rs11191548, and rs3824755. These data suggest that the 10q24.32 locus may harbor multiple causal variants for BP phenotypes. 24 The ARL3 gene encodes ADP-ribosylation factor-like 3, a member of the ADPribosylation factor family of GTP-binding proteins. 25 Mutations of the ARL3 gene cause Bardet-Beidl syndrome, a heterogeneous disorder that increases the risk of hypertension and diabetes mellitus. 26 Physiological support for a role of ARL3 in BP is evidenced by animal experiments showing that ARL3 gene knockout mice develop elevated BP. 27 Although ARL3 represents an interesting BP candidate gene, the identified variant rs4919669 lies in an intronic region and is not in high LD with any coding variant. To assess the potential functional impact of rs4919669, we calculated its Genome Wide Annotation of Variant (GWAVA) score. 28 With a region score of 0.37, transcription start site score of 0.34, and unmatched score of 0.56, this SNP is unlikely to GWAS Meta-Analysis of Long-Term Average BP be pathogenic. However, 3 nearby SNPs in high LD with rs4919669, including rs8354 (r 2 =0.96), rs11191355 (r 2 =0.59), and rs2298278 (r 2 =0.79), had high GWAVA scores (GWAVA scores range from 0.51 to 0.74), indicating likely pathological consequences of these SNPs. Future sequencing and functional studies will be needed to better understand the causal mechanism underlying this association.
Discussion
Gene-based analysis provided the first robust evidence of associations for the KCNJ11 gene with LTA SBP and LTA MAP. The KCNJ11 gene encodes member 11 of inwardly rectifying subfamily J of the potassium channel. This gene has been identified in several GWAS and a GWAS meta-analysis of type 2 diabetes mellitus. [29] [30] [31] [32] Interestingly, an association between this gene and BP was suggested previously in a candidate gene study by Sakamoto et al. 33 However, the association was not significant after adjustment for multiple testing, and no evidence of replication data was available in the study by Sakamoto et al. 33 In addition to previous studies in human populations, animal experiments provide further support of a KCNJ11-BP association. Kane et al 34 reported that KCNJ11 gene knockout mice developed hypertension and were vulnerable to heart failure and death. The KCNJ11 gene signal was missed in the single-marker analysis, highlighting the gain of power and potential utility of gene-based analysis. In addition, sensitivity analysis excluding the most significant SNP within KCNJ11 showed significant gene-based associations of KCNJ11 with both LTA SBP and LTA MAP, indicating that multiple causal variants may attribute to the gene-based signal. Future studies are warranted to identify the causal variants underlying this gene-based signal.
The current analysis transethnically replicated 2 associations at the KCNK3 locus, which were identified in a previous GWAS meta-analysis of LTA BP in a predominantly European population by Ganesh et al. 8 With follow-up analysis in an Asian population, Ganesh et al 8 showed an association of this locus with single-visit BP. Our analysis provides the first direct evidence of replication for this locus with LTA BP. The KCNK3 gene encodes a member of the superfamily of potassium channel proteins and is involved in metabolism of potassium, which has well-known protective effects on BP. 35 Furthermore, functional studies demonstrated that Task1-null littermate mice (kcnk3 knockouts) had significantly lower MAP (≈9 mm Hg) compared with wild-type littermate mice. 8, 36 In addition to identifying novel variants and genes in East Asian populations, both single-marker and gene-based analyses confirmed signals reported by previous BP GWAS meta-analyses. Single-marker analyses verified 9 associations at 3 previously identified BP loci, including WBP1L, NT5C2, and ATP2B1. Furthermore, gene-based analysis identified 14 genes that were implicated previously by single-marker analyses, including TMEM180, ACTR1A, SUFU, ARL3, SFXN2, WBP1L, CYP17A1, C10orf32, C10orf32-ASMT, AS3MT, CNNM2, and NT5C2 at 10q24.32; gene ATP2B1 at 12q21.33; and gene NCR3LG1 at 11p15.1. Although numerous genes at 10q24.32 were implicated by this study, it is unlikely that all are causally associated with BP given the high LD of variants in numerous genes across this region. 7, 11 Functional studies will likely be necessary to identify the causal genomic mechanisms at this gene dense locus.
Our study represents the first GWAS meta-analysis of LTA BP conducted in Asians. Additional study strengths include the adherence of all studies to a standard analytic protocol and stringent genotyping and imputation quality control at the study and meta-analysis levels. Although the current analysis had fewer participants compared with the previously conducted GWAS meta-analysis of single-visit BP in the AGEN consortium, we were able to identify a novel variant and a novel gene associated with BP, highlighting the importance of exploring novel phenotypes and gene-based analysis in the identification of BP loci. Certain limitations should be acknowledged for our study. Some novel loci identified in the discovery stage may be specific to the Asian population. Because only transethnic replication could be conducted, the current study is not able to robustly identify such loci. However, gene-based analyses were used, which may be more consistent across populations because these methods are based on the entire functional unit. 
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In addition, we used fixed-effect models to assess the additive associations between SNPs and BP, assuming that genetic variants have similar effects across studies. Although our study participants were all of East Asian ancestry, there might be heterogeneity in genetic effects because of differences in age and other covariables. 37 In this case, we may have missed some genetic loci whose effects can be modified by such factors. Finally, because we only examined common variants, future studies will be necessary to identify important low-frequency and rare variants influencing LTA BP.
In conclusion, we conducted the first GWAS meta-analysis of LTA BP phenotypes in an Asian population. The current study identified a novel association of the ARL3 gene variant rs4919669 with LTA BP phenotypes in single-marker analysis and an association of the KCNJ11 gene in gene-based analyses. Furthermore, through transethnic replication study, we are the first to report an . AGEN indicates Asian Genetic Epidemiology Network; CHARGE, Cohorts for Heart and Aging Research in Genomic Epidemiology; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; and SBP, systolic blood pressure. GWAS Meta-Analysis of Long-Term Average BP association of the KCNK3 gene locus with LTA BP phenotypes in East Asians. In aggregate, our findings highlight the utility of examining novel phenotypes and conducting gene-based analyses to identify novel genes and variants. Furthermore, we add to the accumulating evidence of reproducible genomic associations across populations with distinct LD structure. 
